FRACTA THERAPEUTICS AS

Signals

3 flags

• ▼ Negativ egenkapital 2025 Bokført egenkapital er negativ (−27k kr).
• ⚑ Under avvikling Selskapet er under frivillig avvikling.
• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−116k kr).

FRACTA THERAPEUTICS AS is registered as a limited company in Oslo, Oslo with organisation number 926960288. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2021. Registered share capital is NOK 30,000, divided into 12000 shares. The company's stated purpose is: “Å utvikle, produsere og selge produkter innenfor bioteknologi og tilgrensende områder. Formålet kan fremmes ved deltagelse i eller samarbeid med andre foretak i inn- og utland eller rådgivende virksomhet.”.

Former names: NODE BIOTECH AS

Key figures · 2025

Operating profit

NOK −116,000

▼ −2520 %

Equity

NOK −27,000

▼ −299 %

Financial health · 2025

Liquidity

2.53

Very good

Current assets ÷ current liabilities

Profitability

-926.2%

Not satisfactory

Return on total assets

Solidity

-296.6%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns FRACTA THERAPEUTICS AS?

MJAALAND CAPITAL AS Org. no. 924984376

33.3%

ØIEN EQUITIES AS Org. no. 925004596

33.3%

STAV-NORAAS HOLDING AS Org. no. 925832065

33.3%

FRACTA THERAPEUTICS AS

· NOK −116,000 profit

FRACTA THERAPEUTICS AS has 3 registered shareholders:

• MJAALAND CAPITAL AS 33.3%
• ØIEN EQUITIES AS 33.3%
• STAV-NORAAS HOLDING AS 33.3%

All shareholders and roles →

Frequently asked questions about FRACTA THERAPEUTICS AS

Who owns FRACTA THERAPEUTICS AS?

MJAALAND CAPITAL AS is the largest registered owner, with 33.3%.

Where is FRACTA THERAPEUTICS AS based?

FRACTA THERAPEUTICS AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.